Empowering Faith-based Communities to Provide Personalized Diabetes Self-management Education and Support (DSMES) in the Magic City: A Pilot Study
MCPILOTDSMES
2 other identifiers
interventional
30
1 country
1
Brief Summary
In this study, individuals living with diabetes in the Birmingham area will participate in a free, 3-month DSMES program hosted by MedsPLUS Consulting, a local independent pharmacy and wellness center, at a local faith-based organization. DSMES sessions meet twice a month and typically address topics including physical activity, nutrition, coping, and reducing risk and complications. Prior to beginning the program, participants will complete a questionnaire that assesses diabetes self-management behaviors (such as diet, physical activity, and medication adherence) and diabetes knowledge. Additionally, they will participate in a biometric screening where clinical data such as blood A1C, blood pressure, blood cholesterol, and BMI are collected. This data will also be collected again after the completion of the program. In this program, participants will be assigned a community health worker who will contact them outside of scheduled DSMES sessions to provide support. Participants will also be randomly assigned to one of two cohorts, the Traditional cohort and the Remote Patient Monitoring (RPM) cohort. The traditional cohort will use paper trackers to track blood pressure and blood sugar outside of DSMES sessions while the RPM cohort will utilize an RPM platform to track this data.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Apr 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2026
CompletedFirst Submitted
Initial submission to the registry
April 22, 2026
CompletedFirst Posted
Study publicly available on registry
April 29, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 1, 2026
April 29, 2026
March 1, 2026
2 months
April 22, 2026
April 22, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change from Baseline in HbA1C results at 12 weeks
HbA1C provides a person's average blood sugar over a 3 month period and will be measured at baseline and the end of the program via fingerprick test. The range of the test is from 4% to 14%. Normal ranges are from 4 to 5.6%, Prediabetes ranges are from 5.7% to 6.4%, Diabetes ranges are from 6.5% and above.
From enrollment to end of treatment at 12 weeks
Secondary Outcomes (8)
Change from Baseline in BMI at 12 weeks
From enrollment to end of treatment at 12 weeks
Change from Baseline in systolic blood pressure at 12 weeks
From baseline to the end of treatment at 12 weeks
Change from Baseline in Diastolic Blood Pressure at 12 weeks
From enrollment to the end of treatment at 12 weeks
Change from Baseline in Total Cholesterol at 12 weeks
From enrollment to the end of treatment at 12 weeks
Change from Baseline in Low-Density Lipoprotein (LDL) Cholesterol at 12 weeks
From enrollment to the end of treatment at 12 weeks
- +3 more secondary outcomes
Other Outcomes (2)
Change in Diabetes Self-management Behaviors at Baseline and 12 weeks
From enrollment to the end of treatment at 12 weeks
Change in Diabetes Knowledge from Baseline and 12 weeks
From enrollment to the end of treatment at 12 weeks
Study Arms (2)
Traditional Cohort
ACTIVE COMPARATORUtilizes paper trackers to track blood glucose and blood pressure readings outside of DSMES sessions
Remote Patient Monitoring (RPM) Cohort
EXPERIMENTALUtilizes remote patient monitoring platform to track blood pressure and blood glucose readings outside of DSMES sessions
Interventions
Participants will be randomly-assigned to one of two cohorts. One cohort will participate in a faith-based DSMES program and use remote patient monitoring (RPM) to track their health throughout the duration. Remote patient monitoring allows a participant's healthcare team to visualize and monitor health data outside of scheduled DSMES sessions. These participants will be given blood pressure and blood glucose tracking devices that utilize Bluetooth to automatically upload their health data into an RPM platform, Prevounce, once measurements are taken.
The Traditional Cohort will also participate in the DSMES program but instead will be provided traditional blood pressure cuffs and glucometers that will not upload their data to a mobile platform to track their health data. These participants will use traditional means (paper trackers) to track their health data and will provide health updates during scheduled communication with community health workers.
Eligibility Criteria
You may qualify if:
- Have a prior diabetes (Type 1, Type 2, or Gestational) or prediabetes diagnosis
- Are aged 18 or older
- Live in Jefferson County, Alabama
- Have never participated in a DSMES program
You may not qualify if:
- Not a resident of Jefferson County, Alabama
- Completed a DSMES program
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
New Hope Baptist Church
Birmingham, Alabama, 35211, United States
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Bertha Hidalgo, PhD
University of Alabama at Birmingham
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
April 22, 2026
First Posted
April 29, 2026
Study Start
April 1, 2026
Primary Completion (Estimated)
June 1, 2026
Study Completion (Estimated)
June 1, 2026
Last Updated
April 29, 2026
Record last verified: 2026-03